Podcast

Dr. Jacqueline Zillioux discusses same-day discharge after FPMRS cases

Author(s):

Urology Times staff

“Same-day discharge is safe and feasible across a broad spectrum of FPMRS cases,” says Jacqueline Zillioux, MD.

In this episode, Urology Times® Managing Editor Ben Saylor spoke with Jacqueline Zillioux, MD. She discusses the safety and feasibility of same-day discharge after female pelvic medicine and reconstructive surgery cases. Zillioux is a urologist at Cleveland Clinic.

Related Videos
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Patient talking with doctor | Image Credit: © bongkarn - stock.adobe.com
Shaya Taghechian, MD, answers a question during a video interview
doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
Raveen Syan, MD, FPMRS, answers a question during a Zoom video interview
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Cassandra K. Kisby, MD, MS, answers a question during a Zoom video interview
Vikas Desai, MD, answers a question during a Zoom video interview
Related Content
Vaginal estrogen for GSM not associated with major adverse cardiovascular events
October 28th 2024

Vaginal estrogen for GSM not associated with major adverse cardiovascular events

Hannah Clarke
“These findings support the safety of vaginal estrogen for treatment of local menopause symptoms, even in high-risk women,” says Gabriella M. Rustia, MD.
Former MLB player Dave Winfield shares lessons from baseball, philanthropy
November 15th 2024

Former MLB player Dave Winfield shares lessons from baseball, philanthropy

Urology Times staff
In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.
Collaboration to advance market launch of ProVate device for pelvic organ prolapse
September 6th 2024

Collaboration to advance market launch of ProVate device for pelvic organ prolapse

Hannah Clarke
The company expects the device to become available for US patients with pelvic organ prolapse in September 2024.
Key updates from the AUA/ASRM male infertility guideline amendment
September 23rd 2024

Key updates from the AUA/ASRM male infertility guideline amendment

Urology Times staff
In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.
National Urogynecology Research Agenda: A Path Forward for Advancing the Treatment and Management of Pelvic Floor Disorders
March 25th 2024

National Urogynecology Research Agenda: A Path Forward for Advancing the Treatment and Management of Pelvic Floor Disorders

American Urogynecologic Society
Developed by the AUGS Scientific Committee and Research Agenda Writing Group
FDA approves cefepime/enmetazobactam for complicated UTI
February 27th 2024

FDA approves cefepime/enmetazobactam for complicated UTI

Hannah Clarke
The FDA approval is supported by data from the phase 3 ALLIUM trial, which demonstrated the non-inferiority and superiority of cefepime/enmetazobactam vs piperacillin/tazobactam.
© 2024 MJH Life Sciences

All rights reserved.